Olink

Olink®
Part of Thermo Fisher Scientific

Clarity in complexity

Olink® Target 48 Neurodegeneration

Absolute quantification. Key markers. Profound insights

There is a critical need for a tool that enables the detection of key neurodegenerative disease biomarkers from plasma samples to enhance analysis of patient material within clinical trials. A high-performance absolute quantification solution is urgently required to ensure precise, reliable, and reproducible results across and within longitudinal studies.

Target 48 Neurodegeneration

Join our neurology spotlight series and get updated information on coming soon Target 48 Neurodegeneration Panel

Register now

Coming soon – Target 48 Neurodegeneration panel

Overview

  • Proteins*

    42 1 Panel

  • Samples

    40 per Kit

  • Sample volume

    1 µL per panel

  • Readout

    pg/mL Absolute units

  • Runs on

    Signature Q100

    Learn more

*anticipated in the final product


Ready to take the next step?

Contact us to discover more and preorder your kit.

Contact us

Absolute quantification

Compare across cohorts, time points, and studies, empowered by precise absolute quantification. Generate rich, robust data from just a few microlitres of plasma or CSF, maximizing the value of each precious sample.


Key markers

Quantify pTau217, Aβ40, Aβ42, NfL, GFAP, and more in a single, scalable assay—saving time, cost, and precious patient sample.


Profound insights

Uncover disease-driving biology with biomarker content purposefully curated by global experts and biobank data, spanning synaptic proteins, neuroinflammation, clearance, and beyond.


Elevate your immunoassay experience

Beyond the Olink panel lies a wide range of free tools for study design, statistical analysis, data visualization and quality control. There’s also continuous support from our data science experts and customer service teams. We’re proud to be active partners to thousands of researchers, from small lab teams to major institutions and consortia.